Literature DB >> 23681869

Hypertension - a clinical update for physicians.

Muntaser D Musameh1, Maciej Tomaszewski, Bryan Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23681869      PMCID： PMC4952637          DOI： 10.7861/clinmedicine.13-2-182

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  10 in total

1.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

2.  Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals.

Authors:  Tine W Hansen; Masahiro Kikuya; Lutgarde Thijs; Kristina Björklund-Bodegård; Tatiana Kuznetsova; Takayoshi Ohkubo; Tom Richart; Christian Torp-Pedersen; Lars Lind; Jørgen Jeppesen; Hans Ibsen; Yutaka Imai; Jan A Staessen
Journal:  J Hypertens       Date:  2007-08       Impact factor: 4.844

Review 3.  Global burden of blood-pressure-related disease, 2001.

Authors:  Carlene M M Lawes; Stephen Vander Hoorn; Anthony Rodgers
Journal:  Lancet       Date:  2008-05-03       Impact factor: 79.321

4.  Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

Authors:  John D Bisognano; George Bakris; Mitra K Nadim; Luis Sanchez; Abraham A Kroon; Jill Schafer; Peter W de Leeuw; Domenic A Sica
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

5.  Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).

Authors:  Giuseppe Mancia; Helmut Schumacher; Josep Redon; Paolo Verdecchia; Roland Schmieder; Garry Jennings; Khalid Yusoff; Lars Ryden; G Lisheng Liu; Koon Teo; Peter Sleight; Salim Yusuf
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

6.  Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Neil R Poulter; Peter S Sever
Journal:  Lancet Neurol       Date:  2010-03-11       Impact factor: 44.182

7.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

8.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

9.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis.

Authors:  Robert H Fagard; Véronique A Cornelissen
Journal:  J Hypertens       Date:  2007-11       Impact factor: 4.844

10.  Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study.

Authors:  Kate Lovibond; Sue Jowett; Pelham Barton; Mark Caulfield; Carl Heneghan; F D Richard Hobbs; James Hodgkinson; Jonathan Mant; Una Martin; Bryan Williams; David Wonderling; Richard J McManus
Journal:  Lancet       Date:  2011-08-23       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.